[
    {
        "question_id": "16300_B_567",
        "new_question_id": "28762",
        "question_type": "0",
        "category": "5",
        "concept_id_link": "10928",
        "notes_id_link": "1_138",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Intramuscular benzylpenicillin now",
            "Intravenous benzylpenicillin if they develop symptoms",
            "Intravenous cefotaxime now",
            "Oral ciprofloxacin if they develop any symptoms",
            "Oral ciprofloxacin now",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 20-year-old university student is brought to the emergency department by her flatmates, with confusion and fever. Since yesterday, she had been complaining of a severe headache and neck stiffness. Her flatmates have also noticed what looks like bruising. <br /><br />She appears acutely unwell, pyrexial and has nuchal rigidity upon examination. An extensive purpuric rash is noted, as well as general pallor and mottling.<br /><br />Given the likely diagnosis, what should be offered to her flatmates?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is oral ciprofloxacin. This patient has meningococcal meningitis, as evidenced by the headache, neck stiffness and widespread purpuric rash. Prophylaxis should be offered to household members and close contacts - ciprofloxacin or rifampicin may be used, but ciprofloxacin is the drug of choice.<br /><br />Intramuscular benzylpenicillin is incorrect - this would not be used for prophylaxis. This is suitable in a pre-hospital setting to give to a patient with suspected meningococcal meningitis, as long as it does not delay transit to the hospital.<br /><br />Intravenous benzylpenicillin if they develop symptoms is incorrect - intravenous benzylpenicillin is a potential treatment option for the patient themselves, not for contacts. Furthermore, it should be given immediately to the patient.<br /><br />Intravenous cefotaxime is a treatment option for the patient - not a suitable prophylactic antibiotic to give to the close contacts.<br /><br />Oral ciprofloxacin, if they develop symptoms, is not correct - whilst this is a suitable choice of antibiotic, it should be given now, not waiting until symptoms develop.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 20-year-old university student is brought to the emergency department by her flatmates, with confusion and fever. Since yesterday, she had been complaining of a severe headache and neck stiffness. Her flatmates have also noticed what looks like bruising. <br /><br />She appears acutely unwell, pyrexial and has nuchal rigidity upon examination. An extensive purpuric rash is noted, as well as general pallor and mottling.<br /><br />Given the likely diagnosis, what should be offered to her flatmates?",
        "correct_answer": "5",
        "question_notes": "The correct answer is oral ciprofloxacin. This patient has meningococcal meningitis, as evidenced by the headache, neck stiffness and widespread purpuric rash. Prophylaxis should be offered to household members and close contacts - ciprofloxacin or rifampicin may be used, but ciprofloxacin is the drug of choice.<br /><br />Intramuscular benzylpenicillin is incorrect - this would not be used for prophylaxis. This is suitable in a pre-hospital setting to give to a patient with suspected meningococcal meningitis, as long as it does not delay transit to the hospital.<br /><br />Intravenous benzylpenicillin if they develop symptoms is incorrect - intravenous benzylpenicillin is a potential treatment option for the patient themselves, not for contacts. Furthermore, it should be given immediately to the patient.<br /><br />Intravenous cefotaxime is a treatment option for the patient - not a suitable prophylactic antibiotic to give to the close contacts.<br /><br />Oral ciprofloxacin, if they develop symptoms, is not correct - whilst this is a suitable choice of antibiotic, it should be given now, not waiting until symptoms develop.",
        "answer_order": "5",
        "answer": "5",
        "title": "Meningitis: management of suspected bacterial meningitis",
        "body": "The investigation and management of suspected bacterial meningitis are usually intertwined given the potential negative impact of delayed antibiotic treatment.<br /><br />All patients should be transferred to hospital urgently. If patients are in a pre-hospital setting (for example a GP surgery) and meningococcal disease is suspected then intramuscular benzylpenicillin may be given, as long as this doesn't delay transit to hospital.<br /><br />An ABC approach should be taken initially<br /><ul><li>Airway</li><li>Breathing</li><li>Circulation</li><li>Disability: GCS, ; focal neurological signs; seizures; papilloedema;</li></ul><br />Senior review if any <b>warning signs</b> are present (please see the Meningitis Research Foundation algorithm link for the full list). Examples include:<br /><ul><li>rapidly progressive rash</li><li>poor peripheral perfusion</li><li>respiratory rate < 8 or > 30 / min <i>or</i> pulse rate < 40 or > 140 / min</li><li>pH < 7.3 <i>or</i> WBC< 4 *10<sup>9</sup>/L <i>or</i> lactate > 4 mmol/L</li><li>GCS < 12 or a drop of 2 points</li><li>poor response to fluid resuscitation</li></ul><br />A key decision is when/whether to attempt a lumbar puncture (LP)<br /><ul><li> LPs require an aseptic technique and are potentially technically difficult - this means they may take time and delay other treatment</li><li>on the other hand, having a cerebrospinal fluid (CSF) sample can be very useful in confirming the diagnosis and guiding antibiotic treatment</li><li>as always, patient safety means that if there is any doubt IV antibiotics should be given as a priority</li></ul><br /><b>Lumbar puncture should be delayed</b> in the following circumstances<br /><ul><li><span class=\"concept\" data-cid=\"11937\">signs of severe sepsis or a rapidly evolving rash</span></li><li>severe respiratory/cardiac compromise</li><li>significant bleeding risk</li><li><span class=\"concept\" data-cid=\"3762\">signs of raised intracranial pressure </span><ul><li>focal neurological signs</li><li>papilloedema</li><li>continuous or uncontrolled seizures</li><li><span class=\"concept\" data-cid=\"12313\">GCS \u2264 9</span></li></ul></li></ul><br />Management of patients without indication for delayed LP<br /><ul><li>IV access &rarr; take bloods and blood cultures</li><li><span class=\"concept\" data-cid=\"11935\">lumbar puncture</span><ul><li>if this cannot be done within the first hour, IV antibiotics should be given after blood cultures have been taken</li></ul></li><li>IV antibiotics <ul><li>3 months -  60 years: BNF recommends <span class=\"concept\" data-cid=\"12165\">ceftriaxone</span> </li><li><span class=\"concept\" data-cid=\"11938\">\u226560 years: BNF recommends ceftriaxone + amoxicillin (or ampicillin) for adults </span></li><li>add <span class=\"concept\" data-cid=\"12312\">IV vancomycin if recent prolonged/multiple antibiotic use or travel to areas with highly resistant pneumococci</span></li></ul></li><li><span class=\"concept\" data-cid=\"8595\">IV dexamethasone</span><ul><li>the BNF recommend to '<i>consider adjunctive treatment with dexamethasone (particularly if pneumococcal meningitis suspected in adults), preferably starting before or with first dose of antibacterial, but no later than 12 hours after starting antibacterial; avoid dexamethasone in septic shock, <span class=\"concept\" data-cid=\"11611\">meningococcal septicaemia</span>, or if immunocompromised, or in meningitis following surgery</i>'</li></ul></li><li><span class=\"concept\" data-cid=\"11936\">CT scan is not normally indicated</span></li></ul><br />Management of patients with signs of raised intracranial pressure<br /><ul><li>get critical care input</li><li>secure airway + high-flow oxygen</li><li>IV access &rarr; take bloods and blood cultures</li><li>IV dexamethasone</li><li>IV antibiotics as above</li><li>arrange neuroimaging</li></ul><br />Management of patients with signs of severe sepsis or a rapidly evolving rash<br /><ul><li>get critical care input</li><li>secure airway + high-flow oxygen</li><li>IV access &rarr; take bloods and blood cultures</li><li>IV fluid resuscitation</li><li>IV antibiotics as above</li></ul><br /><h6 class='notes-subheading'>Investigations</h6><br />The bloods that have already been taken should be tested for the following:<br /><ul><li>full blood count</li><li>renal function</li><li>glucose</li><li>lactate </li><li>clotting profile</li><li>CRP</li></ul><br />If an LP has been performed, the CSF should be tested for:<br /><ul><li>glucose, protein, microscopy and culture</li><li>lactate</li><li>meningococcal and pneumococcal PCR</li><li>enteroviral, herpes simplex and varicella-zoster PCR</li><li>consider investigations for TB meningitis</li></ul><br />Additional tests that may be helpful include:<br /><ul><li>blood gases</li><li>throat swab for meningococcal culture</li></ul><br /><h6 class='notes-subheading'>BNF antibiotic guidelines</h6><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Scenario</b></th><th><b>BNF recommendation</b></th></tr></thead><tbody><tr><td>Initial empirical therapy aged < 3 months</td><td>IV cefotaxime + amoxicillin (or ampicillin)</td></tr><tr><td>Initial empirical therapy aged 3 months - 59 years</td><td><span class=\"concept\" data-cid=\"12165\">IV ceftriaxone</span></td></tr><tr><td>Initial empirical therapy aged \u226560 years</td></tr><tr><td>IV ceftriaxone + amoxicillin (or ampicillin)</td></tr><tr><td>Meningococcal meningitis</td><td>IV benzylpenicillin or IV ceftriaxone</td></tr><tr><td><span class=\"concept\" data-cid=\"12559\">Pneumococcal meningitis</span></td><td>IV ceftriaxone</td></tr><tr><td>Meningitis caused by <i>Haemophilus influenzae</i></td><td>IV ceftriaxone)</td></tr><tr><td>Meningitis caused by Listeria</td><td>IV amoxicillin (or ampicillin) + gentamicin</td></tr></tbody></table></div><br />If the patient has a history of immediate hypersensitivity reaction to penicillin or to cephalosporins the BNF recommends using chloramphenicol.<br /><br /><h6 class='notes-subheading'>Management of contacts</h6><br />Prophylaxis needs to be offered to households and close contacts of patients affected with meningococcal meningitis. Prophylaxis should also be offered to people who have been exposed to <span class=\"concept\" data-cid=\"2697\">respiratory secretion</span>, regardless of the closeness of contact. The risk to contacts is highest in the first 7 days but persists for at least 4 weeks.<br /><br />Management<br /><ul><li>people who have been exposed to a patient with confirmed bacterial meningitis should be given prophylactic antibiotics if they have close contact within the <span class=\"concept\" data-cid=\"2696\">7 days before onset</span></li><li><span class=\"concept\" data-cid=\"10928\">oral ciprofloxacin or rifampicin</span> may be used. The Health Protection Agency (HPA) guidelines now state that whilst either may be used ciprofloxacin is the drug of choice as it is widely available and only requires one dose</li><li>meningococcal vaccination should be offered to close contacts when serotype results are available, including booster doses to those who had the vaccine in infancy</li><li>for pneumococcal meningitis, no prophylaxis is generally needed. There are however exceptions to this. If a cluster of cases of pneumococcal meningitis occurs the HPA have a protocol for offering close contacts antibiotic prophylaxis. Please see the link for more details</li></ul>",
        "notes_hash": "7a3f7e70d1dae6a55a354c8860caf9ed",
        "knowledge_graph_node_id_link": 11257,
        "concept": "Oral ciprofloxacin or rifampicin is used as prophylaxis for contacts of patients with meningococcal meningitis",
        "concept_percentile": "75",
        "concept_colour": "rgb(127,255,0)",
        "number_attempts": "4646",
        "up_votes": "28",
        "down_votes": "21",
        "column_array": [
            0,
            "764",
            "67",
            "694",
            "58",
            "3063",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Meningitis Research Foundation</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_682\" data-linkid=\"682\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_682\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">21</span><button type=\"button\" style=\"\" id=\"link_dislike_682\" data-linkid=\"682\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_682\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.meningitis.org/getmedia/e8ea82ee-e0e9-466d-8526-572108ad6d06/Adult-Protocol-Poster-Nov-2017\">Meningitis protocol</a></td></tr></table><br><br><table style='width:100%'><tr><td>Health Protection Agency</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_634\" data-linkid=\"634\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_634\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_634\" data-linkid=\"634\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_634\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/688835/Public_health_management_of_meningococcal_disease_guidelines.pdf\">2018 Guidance for public health management of meningococcal disease in the UK </a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_713\" data-linkid=\"713\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_713\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"link_dislike_713\" data-linkid=\"713\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_713\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng240/chapter/Recommendations\">2024 Bacterial meningitis and meningococcal septicaemia guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>BNF</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1483\" data-linkid=\"1483\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1483\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"link_dislike_1483\" data-linkid=\"1483\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1483\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://bnf.nice.org.uk/treatment-summary/medical-emergencies-in-the-community.html\">Medical emergencies in the community</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gIHUJs2eTHA\" data-description=\"Meningitis\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"435\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/gIHUJs2eTHA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gIHUJs2eTHA\" data-description=\"Meningitis\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"435\">Meningitis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_757\" data-mediaid=\"757\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_757\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_757\" data-mediaid=\"757\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_757\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/xQC6L8M6XfU\" data-description=\"(Bacterial) Meningitis Pathophysiology\" data-upvotes=\"13\" data-downvotes=\"4\" data-media=\"434\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/xQC6L8M6XfU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/xQC6L8M6XfU\" data-description=\"(Bacterial) Meningitis Pathophysiology\" data-upvotes=\"13\" data-downvotes=\"4\" data-media=\"434\">(Bacterial) Meningitis Pathophysiology</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_756\" data-mediaid=\"756\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_756\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"media_dislike_756\" data-mediaid=\"756\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_756\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "3762": {
                "concept_text": "Meningitis- no LP if signs of raised ICP",
                "concept_percentile": "96"
            },
            "8595": {
                "concept_text": "Dexamethasone improves outcomes (by reducing neurological sequelae) in the treatment of bacterial meningitis",
                "concept_percentile": "97"
            },
            "10928": {
                "concept_text": "Oral ciprofloxacin or rifampicin is used as prophylaxis for contacts of patients with meningococcal meningitis",
                "concept_percentile": "75"
            },
            "11935": {
                "concept_text": "Suspected bacterial meningitis: an LP should be done before IV antibiotics, unless:\n   - cannot be done within 1 hour\n   - signs of severe sepsis or a rapidly evolving rash\n   - significant bleeding risk\n   - signs of raised intracranial pressure",
                "concept_percentile": "94"
            },
            "12165": {
                "concept_text": "In a hospital setting, suspected bacterial meningitis should be treated with IV ceftriaxone for adults < 60 years",
                "concept_percentile": "84"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_1437",
        "new_question_id": "59615",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "4799",
        "notes_id_link": "1_660",
        "theme": "Neurotransmitter changes underlying acute alcohol withdrawal",
        "instruction": "",
        "options": [
            "",
            "Decreased GABA and increased NMDA glutamate transmission",
            "Increased GABA and decreased NMDA glutamate transmission",
            "Increased dopamine and decreased serotonin transmission",
            "Decreased acetylcholine and increased noradrenaline transmission",
            "Increased serotonin and decreased dopamine transmission",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 54-year-old man is admitted to the acute medical unit with agitation, tremor and sweating 10 hours after his last alcoholic drink. He has a history of alcohol dependence but no previous seizures or delirium. Which neurotransmitter changes are most responsible for his current symptoms?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Decreased GABA and increased NMDA glutamate transmission</b> is the correct answer. Chronic alcohol use enhances inhibitory GABAergic tone and suppresses excitatory NMDA-mediated glutamatergic activity in the brain. Abrupt cessation leads to a sudden drop in GABA inhibition alongside upregulated (increased) NMDA receptor activity, resulting in CNS hyperexcitability\u2014manifesting as tremor, agitation, tachycardia, anxiety, and risk of seizures or delirium tremens. Recognising this neurochemical basis is key to understanding both clinical features and rationale for benzodiazepine therapy.<br /><br /><b>Increased GABA and decreased NMDA glutamate transmission</b> describes the effects of ongoing alcohol intoxication rather than withdrawal. Alcohol acutely potentiates GABAergic inhibition while inhibiting excitation via NMDA receptors; withdrawal produces the opposite effect.<br /><br /><b>Increased dopamine and decreased serotonin transmission</b> does not account for the primary pathophysiology of alcohol withdrawal. Dopaminergic pathways are more relevant to substance reward mechanisms than acute withdrawal syndromes.<br /><br /><b>Decreased acetylcholine and increased noradrenaline transmission</b> may contribute to some symptoms seen in other forms of delirium or withdrawal from different substances (e.g., anticholinergic toxicity), but these are not central to alcohol withdrawal's main neurochemical changes.<br /><br /><b>Increased serotonin and decreased dopamine transmission</b> is not implicated in the pathogenesis of alcohol withdrawal symptoms; serotonergic changes can affect mood but do not explain autonomic instability or seizures seen here.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 54-year-old man is admitted to the acute medical unit with agitation, tremor and sweating 10 hours after his last alcoholic drink. He has a history of alcohol dependence but no previous seizures or delirium. Which neurotransmitter changes are most responsible for his current symptoms?",
        "correct_answer": "1",
        "question_notes": "<b>Decreased GABA and increased NMDA glutamate transmission</b> is the correct answer. Chronic alcohol use enhances inhibitory GABAergic tone and suppresses excitatory NMDA-mediated glutamatergic activity in the brain. Abrupt cessation leads to a sudden drop in GABA inhibition alongside upregulated (increased) NMDA receptor activity, resulting in CNS hyperexcitability\u2014manifesting as tremor, agitation, tachycardia, anxiety, and risk of seizures or delirium tremens. Recognising this neurochemical basis is key to understanding both clinical features and rationale for benzodiazepine therapy.<br /><br /><b>Increased GABA and decreased NMDA glutamate transmission</b> describes the effects of ongoing alcohol intoxication rather than withdrawal. Alcohol acutely potentiates GABAergic inhibition while inhibiting excitation via NMDA receptors; withdrawal produces the opposite effect.<br /><br /><b>Increased dopamine and decreased serotonin transmission</b> does not account for the primary pathophysiology of alcohol withdrawal. Dopaminergic pathways are more relevant to substance reward mechanisms than acute withdrawal syndromes.<br /><br /><b>Decreased acetylcholine and increased noradrenaline transmission</b> may contribute to some symptoms seen in other forms of delirium or withdrawal from different substances (e.g., anticholinergic toxicity), but these are not central to alcohol withdrawal's main neurochemical changes.<br /><br /><b>Increased serotonin and decreased dopamine transmission</b> is not implicated in the pathogenesis of alcohol withdrawal symptoms; serotonergic changes can affect mood but do not explain autonomic instability or seizures seen here.",
        "answer_order": "1",
        "answer": "1",
        "title": "Alcohol withdrawal",
        "body": "Mechanism<br /><ul><li>chronic alcohol consumption enhances GABA mediated inhibition in the CNS (similar to benzodiazepines) and inhibits NMDA-type glutamate receptors</li><li>alcohol withdrawal is thought to be lead to the opposite (<span class=\"concept\" data-cid=\"4799\">decreased inhibitory GABA and increased NMDA glutamate transmission</span>)</li></ul><br /><span class=\"concept\" data-cid=\"805\">Features</span><br /><ul><li>symptoms start at 6-12 hours: tremor, sweating, tachycardia, anxiety</li><li>peak incidence of seizures at 36 hours</li><li>peak incidence of <span class=\"concept\" data-cid=\"11953\">delirium tremens is at 48-72 hours: coarse tremor, confusion, delusions</span>, auditory and visual hallucinations, fever, tachycardia</li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"9667\">patients with a history of complex withdrawals from alcohol (i.e. delirium tremens, seizures, blackouts) should be admitted to hospital for monitoring until withdrawals stabilised</span></li><li>first-line: <span class=\"concept\" data-cid=\"8370\">long-acting benzodiazepines</span> e.g. <span class=\"concept\" data-cid=\"5044\">chlordiazepoxide or diazepam</span>. <span class=\"concept\" data-cid=\"2218\">Lorazepam</span> may be preferable in patients with hepatic failure. Typically given as part of a reducing dose protocol<ul><li><span class=\"concept\" data-cid=\"12255\">lorazepam is often preferred in patients with liver cirrhosis</span>. Lorazepam is metabolised through glucuronidation, which is less affected by liver function. Even in patients with significant liver impairment, glucuronidation tends to remain intact, making lorazepam a safer choice</li><li>chlordiazepoxide, on the other hand, undergoes hepatic oxidation via the cytochrome P450 system, which is significantly impaired in cirrhosis. This can lead to prolonged drug accumulation and an increased risk of toxicity, including sedation and hepatic encephalopathy.</li></ul></li><li>carbamazepine also effective in treatment of alcohol withdrawal</li><li>phenytoin is said not to be as effective in the treatment of alcohol withdrawal seizures</li></ul>",
        "notes_hash": "1b60c9bdddb00f5159556e7dd729fd1c",
        "knowledge_graph_node_id_link": 1183,
        "concept": "Alcohol withdrawal results from decreased inhibitory GABA and increased NMDA glutamate transmission",
        "concept_percentile": "53",
        "concept_colour": "rgb(239,255,0)",
        "number_attempts": "4504",
        "up_votes": "8",
        "down_votes": "6",
        "column_array": [
            0,
            "2933",
            "1235",
            "88",
            "140",
            "108",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 0,
        "concepts_for_notes": {
            "805": {
                "concept_text": "Alcohol withdrawal\r\n   - symptoms: 6-12 hours\r\n   - seizures: 36 hours\r\n   - delirium tremens: 72 hours",
                "concept_percentile": "94"
            },
            "4799": {
                "concept_text": "Alcohol withdrawal results from decreased inhibitory GABA and increased NMDA glutamate transmission",
                "concept_percentile": "53"
            },
            "8370": {
                "concept_text": "Decreasing doses of long-acting benzodiazepines are used in the management of alcohol withdrawal",
                "concept_percentile": "71"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "2652_B_59",
        "new_question_id": "13869",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "2684",
        "notes_id_link": "1_1237",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "It is advised that paroxetine be avoided during pregnancy unless the benefits outweigh the risk, as the mother is more likely to experience serotonin syndrome",
            "It is advised that while no studies have been carried out, paroxetine is generally regarded as safe to use during pregnancy",
            "It is advised that while no studies have been carried out, paroxetine is generally regarded as safe to use during pregnancy, but folic acid should be taken at 5mg/day",
            "It is advised that paroxetine be avoided during pregnancy unless the benefits outweigh the risk, as paroxetine can lead to an increased risk of congenital malformations",
            "It is advised that while no studies have been carried out, psychiatric medicines are always avoided in pregnancy",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A young woman who is planning to get pregnant is currently taking paroxetine and wants to know if it will have any adverse effects during pregnancy.  What should you advise her?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "SSRIs and pregnancy<br /><ul><li>   BNF says to weigh up benefits and risk when deciding whether to use in pregnancy.</li><li>   Use during the first trimester gives a small increased risk of congenital heart defects</li><li>   Use during the third trimester can result in persistent pulmonary hypertension of the newborn</li><li>   Paroxetine has an increased risk of congenital malformations, particularly in the first trimester</li></ul>",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A young woman who is planning to get pregnant is currently taking paroxetine and wants to know if it will have any adverse effects during pregnancy.  What should you advise her?",
        "correct_answer": "4",
        "question_notes": "SSRIs and pregnancy<br /><ul><li>   BNF says to weigh up benefits and risk when deciding whether to use in pregnancy.</li><li>   Use during the first trimester gives a small increased risk of congenital heart defects</li><li>   Use during the third trimester can result in persistent pulmonary hypertension of the newborn</li><li>   Paroxetine has an increased risk of congenital malformations, particularly in the first trimester</li></ul>",
        "answer_order": "4",
        "answer": "4",
        "title": "Selective serotonin reuptake inhibitors",
        "body": "Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment for the majority of patients with depression. <br /><ul><li>citalopram (although see below re: QT interval) and fluoxetine are currently the preferred SSRIs</li><li><span class=\"concept\" data-cid=\"2415\">sertraline is useful post myocardial infarction</span> as there is more evidence for its safe use in this situation than other antidepressants</li><li>SSRIs should be used with caution in <span class=\"concept\" data-cid=\"243\">children and adolescents. Fluoxetine is the drug of choice</span> when an antidepressant is indicated</li></ul><br />Adverse effects<br /><ul><li>gastrointestinal symptoms are the most common side-effect</li><li>there is an increased risk of gastrointestinal bleeding in patients taking SSRIs. A proton pump inhibitor should be prescribed if a patient is also taking a NSAID</li><li>patients should be counselled to be vigilant for increased anxiety and agitation after starting a SSRI</li><li>fluoxetine and paroxetine have a higher propensity for drug interactions</li></ul><br /><span class=\"concept\" data-cid=\"9510\">Citalopram and the QT interval</span><br /><ul><li>the Medicines and Healthcare products Regulatory Agency (MHRA) released a warning on the use of citalopram in 2011</li><li>it advised that citalopram and escitalopram are associated with dose-dependent QT interval prolongation and should not be used in those with: congenital long QT syndrome; known pre-existing QT interval prolongation; or in combination with other medicines that prolong the QT interval</li><li>the maximum daily dose is now 40 mg for adults; 20 mg for patients older than 65 years; and 20 mg for those with hepatic impairment</li></ul><br />Interactions<br /><ul><li><span class=\"concept\" data-cid=\"242\">NSAIDs</span>: NICE guidelines advise 'do not normally offer SSRIs', but if given co-prescribe a proton pump inhibitor</li><li><span class=\"concept\" data-cid=\"2414\">warfarin</span> / heparin: NICE guidelines recommend avoiding SSRIs and considering mirtazapine</li><li>aspirin</li><li><span class=\"concept\" data-cid=\"8281\">triptans</span> - increased risk of serotonin syndrome</li><li><span class=\"concept\" data-cid=\"1140\">monoamine oxidase inhibitors (MAOIs)</span> - increased risk of serotonin syndrome</li></ul><br />Following the initiation of antidepressant therapy patients should normally be reviewed by a doctor after 2 weeks. For <span class=\"concept\" data-cid=\"11945\">patients under the age of 25 years or at increased risk of suicide should be reviewed after 1 week</span>. If a patient makes a good response to antidepressant therapy they should continue on treatment for at least <span class=\"concept\" data-cid=\"1143\">6 months</span> after remission as this reduces the risk of relapse. <br /><br />When stopping a SSRI the dose should be gradually reduced over a <span class=\"concept\" data-cid=\"8280\">4 week</span> period (this is not necessary with fluoxetine). <span class=\"concept\" data-cid=\"241\">Paroxetine has a higher incidence of discontinuation symptoms</span>.<br /><br /><span class=\"concept\" data-cid=\"1144\">Discontinuation symptoms</span><br /><ul><li>increased mood change</li><li>restlessness</li><li>difficulty sleeping</li><li>unsteadiness</li><li>sweating</li><li><span class=\"concept\" data-cid=\"8279\">gastrointestinal symptoms: pain, cramping, diarrhoea, vomiting</span></li><li>paraesthesia</li></ul><br />SSRIs and pregnancy<br />    -    BNF says to weigh up benefits and risk when deciding whether to use in pregnancy.<br />    -    Use during the first trimester gives a small increased risk of congenital heart defects<br />    -    Use during the third trimester can result in <span class=\"concept\" data-cid=\"2681\">persistent pulmonary hypertension</span> of the newborn<br />    -    <span class=\"concept\" data-cid=\"2684\">Paroxetine has an increased risk of congenital malformations</span>, particularly in the first trimester",
        "notes_hash": "68dbd8a42b65755d61d01a8b61c29a88",
        "knowledge_graph_node_id_link": 10859,
        "concept": "Paroxetine use in pregnancy - can lead to increased risk of congenital malformations",
        "concept_percentile": "69",
        "concept_colour": "rgb(158,255,0)",
        "number_attempts": "5478",
        "up_votes": "19",
        "down_votes": "22",
        "column_array": [
            0,
            "612",
            "912",
            "734",
            "3115",
            "105",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_803\" data-linkid=\"803\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_803\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">36</span><button type=\"button\" style=\"\" id=\"link_dislike_803\" data-linkid=\"803\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_803\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">41</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng222/chapter/Recommendations\">2022 Depression in adults: treatment and management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/T25jvLC6X0w\" data-description=\"Antidepressants\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"631\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/T25jvLC6X0w/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/T25jvLC6X0w\" data-description=\"Antidepressants\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"631\">Antidepressants</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1082\" data-mediaid=\"1082\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1082\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_1082\" data-mediaid=\"1082\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1082\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4X5nqkEBmTo\" data-description=\"Antidepressants Pharmacology\" data-upvotes=\"3\" data-downvotes=\"5\" data-media=\"313\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/4X5nqkEBmTo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4X5nqkEBmTo\" data-description=\"Antidepressants Pharmacology\" data-upvotes=\"3\" data-downvotes=\"5\" data-media=\"313\">Antidepressants Pharmacology</a></td></tr><tr><td><span ><small>Soton Brain Hub - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_533\" data-mediaid=\"533\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_533\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_533\" data-mediaid=\"533\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_533\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "242": {
                "concept_text": "SSRI + NSAID = GI bleeding risk - give a PPI",
                "concept_percentile": "78"
            },
            "243": {
                "concept_text": "Fluoxetine is the SSRI of choice in children and adolescents",
                "concept_percentile": "85"
            },
            "1140": {
                "concept_text": "SSRIs and MAOIs should never be combined as there is a risk of serotonin syndrome",
                "concept_percentile": "94"
            },
            "1143": {
                "concept_text": "Antidepressants should be continued for at least 6 months after remission of symptoms to decrease risk of relapse",
                "concept_percentile": "55"
            },
            "1144": {
                "concept_text": "Dizziness, electric shock sensations and anxiety are symptoms of SSRI discontinuation syndrome\r\n",
                "concept_percentile": "96"
            },
            "2415": {
                "concept_text": "Sertraline is the SSRI of choice post myocardial infarction",
                "concept_percentile": "76"
            },
            "2684": {
                "concept_text": "Paroxetine use in pregnancy - can lead to increased risk of congenital malformations",
                "concept_percentile": "69"
            },
            "8279": {
                "concept_text": "Gastrointestinal side-effects such as diarrhoea are seen in SSRI discontinuation syndrome",
                "concept_percentile": "84"
            },
            "8281": {
                "concept_text": "Triptans should be avoided in patients taking a SSRI",
                "concept_percentile": "85"
            },
            "9510": {
                "concept_text": "Citalopram is the most likely SSRI to lead to QT prolongation and Torsades de pointes",
                "concept_percentile": "96"
            },
            "11945": {
                "concept_text": "Patients \u2264  25 years who have been started on an SSRI should be reviewed after 1 week",
                "concept_percentile": "96"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4680_B_131",
        "new_question_id": "17438",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "5226",
        "notes_id_link": "1_2575",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Oestrogen receptor- positive ovarian cancer",
            "Oestrogen receptor-positive breast cancer",
            "Colorectal cancer",
            "Oestrogen receptor-positive endometrial cancer",
            "Oestrogen receptor-negative breast cancer",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 45-year-old female patient is brought into the emergency department by ambulance following a sudden onset facial droop and speech disturbance. On examination, she is alert but appears to have both expressive and receptive aphasia. You access the GP summary record which shows that the only medication she is on is tamoxifen. <br /><br />What would be the most likely condition she has in her past medical history?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Tamoxifen is used in the management of oestrogen receptor-positive breast cancer.<br /><br />Tamoxifen is not used in the treatment of oestrogen receptor-negative breast cancer.<br /><br />Tamoxifen is not used in the treatment of ovarian cancer.<br /><br />Tamoxifen can cause endometrial cancer<br /><br />Tamoxifen is not used in the treatment of colorectal cancer.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 45-year-old female patient is brought into the emergency department by ambulance following a sudden onset facial droop and speech disturbance. On examination, she is alert but appears to have both expressive and receptive aphasia. You access the GP summary record which shows that the only medication she is on is tamoxifen. <br /><br />What would be the most likely condition she has in her past medical history?",
        "correct_answer": "2",
        "question_notes": "Tamoxifen is used in the management of oestrogen receptor-positive breast cancer.<br /><br />Tamoxifen is not used in the treatment of oestrogen receptor-negative breast cancer.<br /><br />Tamoxifen is not used in the treatment of ovarian cancer.<br /><br />Tamoxifen can cause endometrial cancer<br /><br />Tamoxifen is not used in the treatment of colorectal cancer.",
        "answer_order": "2",
        "answer": "2",
        "title": "Anti-oestrogen drugs",
        "body": "<h5 class='notes-heading'>Selective oEstrogen Receptor Modulators (SERM)</h5><br />Tamoxifen is a SERM which acts as an oestrogen receptor antagonist and partial agonist. It is used in the management of <span class=\"concept\" data-cid=\"5226\">oestrogen receptor-positive breast cancer</span>.<br /><br />Adverse effects<br /><ul><li>menstrual disturbance: vaginal bleeding, amenorrhoea</li><li>hot flushes - 3% of patients stop taking tamoxifen due to climacteric side-effects</li><li>venous thromboembolism</li><li>endometrial cancer</li></ul><br /><br /><h5 class='notes-heading'>Aromatase inhibitors</h5><br />Anastrozole and letrozole are <span class=\"concept\" data-cid=\"10990\">aromatase inhibitors that reduces peripheral oestrogen synthesis</span>. This is important as aromatisation accounts for the majority of oestrogen production in <span class=\"concept\" data-cid=\"4931\">postmenopausal women and therefore anastrozole is used for ER +ve breast cancer in this group</span>.<br /><br />Adverse effects<br /><ul><li><span class=\"concept\" data-cid=\"10498\">osteoporosis</span><ul><li><span class=\"concept\" data-cid=\"10641\">NICE recommends a DEXA scan when initiating a patient on aromatase inhibitors for breast cancer</span></li></ul></li><li>hot flushes</li><li>arthralgia, myalgia</li><li>insomnia</li></ul>",
        "notes_hash": "bc26f9f0d2cd573ebb75210486cecc5e",
        "knowledge_graph_node_id_link": 0,
        "concept": "Tamoxifen is used in the management of oestrogen receptor-positive breast cancer in pre-menopausal women",
        "concept_percentile": "37",
        "concept_colour": "rgb(255,188,0)",
        "number_attempts": "6207",
        "up_votes": "31",
        "down_votes": "24",
        "column_array": [
            0,
            "176",
            "5693",
            "16",
            "137",
            "185",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>BNF</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1656\" data-linkid=\"1656\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1656\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"link_dislike_1656\" data-linkid=\"1656\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1656\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">17</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://bnf.nice.org.uk/drug/anastrozole.html\">Anastrozole </a></td></tr></table><br><br><table style='width:100%'><tr><td>BNF</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1655\" data-linkid=\"1655\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1655\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_1655\" data-linkid=\"1655\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1655\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">15</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://bnf.nice.org.uk/drug/tamoxifen.html\">Tamoxifen</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1OJQsP_9i_I\" data-description=\"Aromatase inhibitors\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1453\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/1OJQsP_9i_I/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1OJQsP_9i_I\" data-description=\"Aromatase inhibitors\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1453\">Aromatase inhibitors</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2565\" data-mediaid=\"2565\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2565\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2565\" data-mediaid=\"2565\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2565\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "4931": {
                "concept_text": "Aromatase inhibitors are used in the treatment of ER +ve breast cancer in post-menopausal women",
                "concept_percentile": "21"
            },
            "5226": {
                "concept_text": "Tamoxifen is used in the management of oestrogen receptor-positive breast cancer in pre-menopausal women",
                "concept_percentile": "37"
            },
            "10498": {
                "concept_text": "Aromatase inhibitors (e.g. anastrozole) may cause osteoporosis",
                "concept_percentile": "55"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "5650_B_513",
        "new_question_id": "41291",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "1483",
        "notes_id_link": "1_1800",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Intravenous hydrocortisone",
            "Oral aciclovir",
            "Oral aspirin",
            "Oral prednisolone",
            "Oral sumatriptan",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 45-year-old woman presents to the emergency department with a 2-day history of left-sided facial droop.  She denies any limb weakness, visual disturbance, or difficulty swallowing.  She reports noticing that when she speaks, she finds her voice loud and distorted.  On examination, there is left facial paralysis and the patient is unable to raise her eyebrow.  Peripheral neurological examination is unremarkable. Her only past medical history is migraine and anxiety.  She has no known drug allergies.  <br /><br /><br />What is the most appropriate first-line medical management?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "This woman is presenting with a lower motor neuron facial palsy (as there is forehead involvement) alongside hyperacusis - this is in keeping with <u>Bell's palsy</u> and should be managed with <b>oral prednisolone</b> as she is presenting within 72 hours of symptom onset.  This woman appears to be systemically well and can be discharged to complete a 10-day course of steroids (or a high-dose course for 5 days with a subsequent reducing regime).  <br /><br /><b>Intravenous hydrocortisone</b> is not the preferred corticosteroid management for patients with Bell's palsy.  This is due to the necessity to administer the steroids for a 10-day course.  It would be inappropriate to keep a patient who is otherwise well in hospital for 10 days only to administer corticosteroids intravenously when oral management has been proven to be as effective in clinical trials.<br /><br /><b>Aciclovir</b> is an antiviral that is used in the management of herpes zoster.  Current NICE guidelines do not recommend the use of antivirals alone or antivirals combined with corticosteroids in the management of Bell's palsy.  This is due to insufficient evidence that either of these options is superior to the administration of corticosteroids only.<br /><br /><b>Oral aspirin</b> would be used in the long-term management of an ischaemic stroke.  It is not recommended for management during a suspected stroke or before imaging due to the risk of a haemorrhagic stroke being present rather than an ischaemic stroke.  As this patient has forehead involvement, it is unlikely to be a stroke.  This is due to a stroke being an upper motor neuron lesion that causes forehead sparing (while Bell's palsy is a lower motor neuron lesion).  <br /><br /><b>Sumatriptan</b> is given in the management of migraine.  While this patient has a history of migraines, her presentation today is not consistent with migraines (which usually have symptoms of headache, nausea, and photophobia).",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 45-year-old woman presents to the emergency department with a 2-day history of left-sided facial droop.  She denies any limb weakness, visual disturbance, or difficulty swallowing.  She reports noticing that when she speaks, she finds her voice loud and distorted.  On examination, there is left facial paralysis and the patient is unable to raise her eyebrow.  Peripheral neurological examination is unremarkable. Her only past medical history is migraine and anxiety.  She has no known drug allergies.  <br /><br /><br />What is the most appropriate first-line medical management?",
        "correct_answer": "4",
        "question_notes": "This woman is presenting with a lower motor neuron facial palsy (as there is forehead involvement) alongside hyperacusis - this is in keeping with <u>Bell's palsy</u> and should be managed with <b>oral prednisolone</b> as she is presenting within 72 hours of symptom onset.  This woman appears to be systemically well and can be discharged to complete a 10-day course of steroids (or a high-dose course for 5 days with a subsequent reducing regime).  <br /><br /><b>Intravenous hydrocortisone</b> is not the preferred corticosteroid management for patients with Bell's palsy.  This is due to the necessity to administer the steroids for a 10-day course.  It would be inappropriate to keep a patient who is otherwise well in hospital for 10 days only to administer corticosteroids intravenously when oral management has been proven to be as effective in clinical trials.<br /><br /><b>Aciclovir</b> is an antiviral that is used in the management of herpes zoster.  Current NICE guidelines do not recommend the use of antivirals alone or antivirals combined with corticosteroids in the management of Bell's palsy.  This is due to insufficient evidence that either of these options is superior to the administration of corticosteroids only.<br /><br /><b>Oral aspirin</b> would be used in the long-term management of an ischaemic stroke.  It is not recommended for management during a suspected stroke or before imaging due to the risk of a haemorrhagic stroke being present rather than an ischaemic stroke.  As this patient has forehead involvement, it is unlikely to be a stroke.  This is due to a stroke being an upper motor neuron lesion that causes forehead sparing (while Bell's palsy is a lower motor neuron lesion).  <br /><br /><b>Sumatriptan</b> is given in the management of migraine.  While this patient has a history of migraines, her presentation today is not consistent with migraines (which usually have symptoms of headache, nausea, and photophobia).",
        "answer_order": "4",
        "answer": "4",
        "title": "Bell's palsy",
        "body": "Bell's palsy may be defined as an acute, unilateral, idiopathic, facial nerve paralysis. The aetiology is unknown although the role of the herpes simplex virus has been investigated previously. The peak incidence is 20-40 years and the condition is more common in pregnant women.<br /><br />Features<br /><ul><li><span class=\"concept\" data-cid=\"5053\">lower motor neuron facial nerve palsy &rarr; forehead affected</span><ul><li>in contrast, an upper motor neuron lesion 'spares' the upper face</li></ul></li><li>patients may also notice <ul><li>post-auricular pain (may precede paralysis)</li><li>altered taste</li><li>dry eyes</li><li>hyperacusis</li></ul></li></ul><br />Management<br /><ul><li>in the past a variety of treatment options have been proposed including no treatment, prednisolone only and a combination of antivirals and prednisolone</li><li>there is consensus that all patients should receive oral prednisolone within 72 hours of onset of Bell's palsy</li><li>there is an ongoing debate as to the value of adding in antiviral medications #link26 <ul><li>Antiviral treatments alone are not recommended</li><li>UpToDate recommends the addition of antivirals for severe facial palsy</li></ul></li><li><span class=\"concept\" data-cid=\"11758\">eye care</span> is important to prevent exposure keratopathy<ul><li>prescription of artificial tears and eye lubricants should be considered</li><li>If they are unable to close the eye at bedtime, they should tape it closed using microporous tape</li></ul></li></ul><br />Follow-up<br /><ul><li>if the paralysis shows no sign of improvement after <concepts1970>3 weeks, refer urgently to ENT</span></li><li>a referral to <span class=\"concept\" data-cid=\"1150\">plastic surgery</span> may be appropriate for patients with more long-standing weakness e.g. several months</li></ul><br />Prognosis<br /><ul><li>most people with Bell's palsy make a <span class=\"concept\" data-cid=\"1965\">full recovery within 3-4 months</span></li><li>if untreated around 15% of patients have permanent moderate to severe weakness</li></ul>",
        "notes_hash": "59ca8ed5a5b140eef0bfdbdbbbf96db4",
        "knowledge_graph_node_id_link": 1143,
        "concept": "All patients with a Bell's palsy should be given oral prednisolone within 72 hours of onset",
        "concept_percentile": "74",
        "concept_colour": "rgb(132,255,0)",
        "number_attempts": "4691",
        "up_votes": "22",
        "down_votes": "5",
        "column_array": [
            0,
            "137",
            "342",
            "144",
            "4030",
            "38",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ic1hKbk4CKc\" data-description=\"Bell's palsy\" data-upvotes=\"11\" data-downvotes=\"0\" data-media=\"553\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ic1hKbk4CKc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ic1hKbk4CKc\" data-description=\"Bell's palsy\" data-upvotes=\"11\" data-downvotes=\"0\" data-media=\"553\">Bell's palsy</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_944\" data-mediaid=\"944\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_944\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"media_dislike_944\" data-mediaid=\"944\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_944\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "5053": {
                "concept_text": "Bell's palsy is a lower motor neuron condition. Unlike UMN conditions of the face, in LMN conditions the entire side of the patients face is affected",
                "concept_percentile": "83"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1158",
        "new_question_id": "2869",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "304",
        "notes_id_link": "1_1463",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Immediately",
            "2 days",
            "5 days",
            "7 days",
            "Until first day of next period",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 36-year-old female starts Cerazette (desogestrel) on day 7 of her cycle. How long will it take before it can be relied upon as a method of contraception?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is <b>2 days</b>. Cerazette (desogestrel) is a progestogen-only pill (POP) that contains 75 micrograms of desogestrel. When started on day 7 of the menstrual cycle, it requires 48 hours (2 days) to become effective as a contraceptive method. This is because desogestrel needs approximately 48 hours to achieve sufficient serum levels to inhibit ovulation and thicken cervical mucus, which are its primary mechanisms of action. The Faculty of Sexual and Reproductive Healthcare (FSRH) guidelines confirm that when starting desogestrel after day 5 of the menstrual cycle, additional contraceptive precautions should be used for 2 days.<br /><br /><b>Immediately</b> is incorrect. Cerazette does not provide immediate contraceptive protection when started on day 7 of the cycle. If Cerazette had been started on day 1-5 of the menstrual cycle, it would have been effective immediately, but since this patient started it on day 7, there is a delay in establishing reliable contraception.<br /><br /><b>5 days</b> is incorrect. This duration is too long for Cerazette to become effective. Traditional progestogen-only pills containing levonorgestrel or norethisterone require 48 hours to become effective, and Cerazette follows the same timeframe despite having different effects on ovulation compared to traditional POPs.<br /><br /><b>7 days</b> is incorrect. This duration applies to combined hormonal contraceptives (CHCs) such as the combined oral contraceptive pill, which typically requires 7 days to establish contraceptive efficacy when started after day 5 of the menstrual cycle. Cerazette, as a POP, has a shorter timeframe of 2 days.<br /><br /><b>Until first day of next period</b> is incorrect. This would represent an unnecessarily long duration without contraceptive protection. Cerazette does not operate on a cycle-dependent basis for establishing efficacy once started. After the initial 2-day period for establishing contraceptive effect, Cerazette provides continuous protection as long as it is taken correctly (within a 12-hour window each day).",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 36-year-old female starts Cerazette (desogestrel) on day 7 of her cycle. How long will it take before it can be relied upon as a method of contraception?",
        "correct_answer": "2",
        "question_notes": "The correct answer is <b>2 days</b>. Cerazette (desogestrel) is a progestogen-only pill (POP) that contains 75 micrograms of desogestrel. When started on day 7 of the menstrual cycle, it requires 48 hours (2 days) to become effective as a contraceptive method. This is because desogestrel needs approximately 48 hours to achieve sufficient serum levels to inhibit ovulation and thicken cervical mucus, which are its primary mechanisms of action. The Faculty of Sexual and Reproductive Healthcare (FSRH) guidelines confirm that when starting desogestrel after day 5 of the menstrual cycle, additional contraceptive precautions should be used for 2 days.<br /><br /><b>Immediately</b> is incorrect. Cerazette does not provide immediate contraceptive protection when started on day 7 of the cycle. If Cerazette had been started on day 1-5 of the menstrual cycle, it would have been effective immediately, but since this patient started it on day 7, there is a delay in establishing reliable contraception.<br /><br /><b>5 days</b> is incorrect. This duration is too long for Cerazette to become effective. Traditional progestogen-only pills containing levonorgestrel or norethisterone require 48 hours to become effective, and Cerazette follows the same timeframe despite having different effects on ovulation compared to traditional POPs.<br /><br /><b>7 days</b> is incorrect. This duration applies to combined hormonal contraceptives (CHCs) such as the combined oral contraceptive pill, which typically requires 7 days to establish contraceptive efficacy when started after day 5 of the menstrual cycle. Cerazette, as a POP, has a shorter timeframe of 2 days.<br /><br /><b>Until first day of next period</b> is incorrect. This would represent an unnecessarily long duration without contraceptive protection. Cerazette does not operate on a cycle-dependent basis for establishing efficacy once started. After the initial 2-day period for establishing contraceptive effect, Cerazette provides continuous protection as long as it is taken correctly (within a 12-hour window each day).",
        "answer_order": "2",
        "answer": "2",
        "title": "Progestogen only pill: counselling",
        "body": "Women who are considering taking the progestogen-only pill (POP) should be counselled in a number of areas:<br /><br />Potential adverse effects<br /><ul><li><span class=\"concept\" data-cid=\"11425\">irregular vaginal bleeding is the most common problem</span></li></ul><br />Starting the POP<br /><ul><li>if commenced up to and including day 5 of the cycle it provides immediate protection, otherwise additional contraceptive methods (e.g. condoms) should be used for the first <span class=\"concept\" data-cid=\"1300\">2 days</span></li><li>if switching from a combined oral contraceptive (COC) gives immediate protection if continued directly from the end of a pill packet (i.e. Day 21)</li></ul><br />Taking the POP<br /><ul><li>should be taken at the same time every day, without a pill-free break (unlike the COC)</li></ul><br />Missed pills<br /><ul><li>if < 3 hours* late: continue as normal</li><li>if > 3 hours*: take the missed pill as soon as possible, continue with the rest of the pack, extra precautions (e.g. condoms) should be used until pill taking has been re-established for 48 hours</li></ul><br />Other potential problems<br /><ul><li>diarrhoea and vomiting: continue taking POP but assume pills have been missed - see above</li><li><span class=\"concept\" data-cid=\"303\">antibiotics: have no effect on the POP</span>**</li><li>liver enzyme inducers may reduce the effectiveness</li></ul><br />Other information<br /><ul><li>discussion on STIs</li></ul><br />*for Cerazette (desogestrel) a 12 hour period is allowed<br /><br />**unless the antibiotic alters the P450 enzyme system, for example, rifampicin",
        "notes_hash": "35abf2da48d662cd60c4815d8b6a7074",
        "knowledge_graph_node_id_link": 0,
        "concept": "Contraceptives - time until effective (if not first day period):<br /><ul><li>instant: IUD</li><li>2 days: POP</li><li>7 days: COC, injection, implant, IUS</li></ul>",
        "concept_percentile": "88",
        "concept_colour": "rgb(61,255,0)",
        "number_attempts": "5409",
        "up_votes": "30",
        "down_votes": "17",
        "column_array": [
            0,
            "407",
            "2837",
            "368",
            "1637",
            "160",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Faculty of Sexual and Reproductive Healthcare</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_133\" data-linkid=\"133\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_133\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"link_dislike_133\" data-linkid=\"133\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_133\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">16</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.fsrh.org/standards-and-guidance/documents/cec-ceu-guidance-pop-mar-2015/\">2015 POP guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 3,
        "concepts_for_notes": {
            "303": {
                "concept_text": "Progestogen only pill + antibiotics - no need for extra precautions",
                "concept_percentile": "84"
            },
            "11425": {
                "concept_text": "Progestogen-only pill: irregular vaginal bleeding is the most common adverse effect",
                "concept_percentile": "58"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "4680_B_30",
        "new_question_id": "14389",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "3065",
        "notes_id_link": "1_1571",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Hormone replacement therapy",
            "Venlafaxine",
            "Tibolone",
            "Topical oestrogen",
            "Combined oral contraceptive pill",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 50-year-old woman presents to the GP surgery complaining of night sweats and hot flushes for the last 12 months. Her last period was 18 months ago. She is currently being treated with tamoxifen for the breast cancer. She is not troubled by any other symptom. She would like to have something that helps the hot flushes.<br /><br />What is the most appropriate medication to prescribe for her?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "This patient has active hormone-responsive breast cancer hence hormonal methods such as HRT and tibolone are contraindicated. An SSRI and venlafaxine are non-hormonal methods that may help vasomotor symptoms of menopause. <br /><br />Topical oestrogen can be used to alleviate symptoms of vaginal atrophy. However, it does not alleviate vasomotor symptoms.<br /><br />COCP is not used to treat menopausal symptoms.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 50-year-old woman presents to the GP surgery complaining of night sweats and hot flushes for the last 12 months. Her last period was 18 months ago. She is currently being treated with tamoxifen for the breast cancer. She is not troubled by any other symptom. She would like to have something that helps the hot flushes.<br /><br />What is the most appropriate medication to prescribe for her?",
        "correct_answer": "2",
        "question_notes": "This patient has active hormone-responsive breast cancer hence hormonal methods such as HRT and tibolone are contraindicated. An SSRI and venlafaxine are non-hormonal methods that may help vasomotor symptoms of menopause. <br /><br />Topical oestrogen can be used to alleviate symptoms of vaginal atrophy. However, it does not alleviate vasomotor symptoms.<br /><br />COCP is not used to treat menopausal symptoms.",
        "answer_order": "2",
        "answer": "2",
        "title": "Menopause: management",
        "body": "Menopause is defined as the permanent cessation of menstruation. It is caused by the loss of follicular activity. Menopause is a clinical diagnosis usually made in primary care when a woman has not had a period for 12 months. <br /><br />Menopausal symptoms are very common and affect roughly 75% of postmenopausal women. Symptoms typically last for 7 years but may resolve quicker and in some cases take much longer. The duration and severity are also variable and may develop before the start of the menopause and in some cases may start years after the onset of menopause.  <br /><br />The CKS has very thorough and clear guidance on the management of menopause and is summarised below. <br /><br />The management of menopause can be split into three categories:<br /><ul><li>Lifestyle modifications</li><li>Hormone replacement therapy (HRT)</li><li>Non-hormone replacement therapy </li></ul><br /><br /><h5 class='notes-heading'>Management with lifestyle modifications</h5><br />Hot flushes<br /><ul><li>regular exercise, weight loss and reduce stress</li></ul><br />Sleep disturbance<br /><ul><li>avoiding late evening exercise and maintaining good sleep hygiene </li></ul><br />Mood<br /><ul><li>sleep, regular exercise and relaxation</li></ul><br />Cognitive symptoms<br /><ul><li>regular exercise and good sleep hygiene </li></ul><br /><br /><h5 class='notes-heading'>Management with HRT</h5><br />Contraindications: <br /><ul><li>Current or past breast cancer</li><li>Any oestrogen-sensitive cancer </li><li>Undiagnosed vaginal bleeding</li><li>Untreated endometrial hyperplasia </li></ul><br />Roughly 10% of women will have some form of HRT to treat their menopausal symptoms. There is a current drive by NICE to increase this number as they have found that women were previously being undertreated due to worries about increased cancer risk. If the woman has a uterus then it is important not to give unopposed oestrogens as this will increase her risk of endometrial cancer. Therefore oral or transdermal combined HRT is given.<br /><br />If the woman does not have a uterus then oestrogen alone can be given either orally or in a transdermal patch.<br /> <br />Women should be advised that the symptoms of menopause typically last for 2-5 years and that treatment with HRT brings certain risks:<br /><ul><li>Venous thromboembolism: a slight increase in risk with all forms of oral HRT. No increased risk with transdermal HRT. </li><li>Stroke: slightly increased risk with oral oestrogen HRT.</li><li>Coronary heart disease: combined HRT may be associated with a slight increase in risk.</li><li>Breast cancer: there is an increased risk with all combined HRT although the risk of dying from breast cancer is not raised. </li><li>Ovarian cancer: increased risk with all HRT.</li></ul><br /><h5 class='notes-heading'>Management with non-HRT</h5><br />Vasomotor symptoms<br /><ul><li><span class=\"concept\" data-cid=\"3065\">fluoxetine, citalopram or venlafaxine</span> </li></ul><br />Vaginal dryness<br /><ul><li>vaginal lubricant or moisturiser </li></ul><br />Psychological symptoms<br /><ul><li>self-help groups, cognitive behaviour therapy or antidepressants</li></ul><br />Urogenital symptoms<br /><ul><li>if suffering from urogenital atrophy vaginal oestrogen can be prescribed. This is appropriate if they are taking HRT or not</li><li>vaginal dryness can be treated with moisturisers and lubricants. These can be offered alongside vaginal oestrogens if required. </li></ul><br /><br /><h5 class='notes-heading'>Stopping treatment</h5><br />For vasomotor symptoms, 2-5 years of HRT may be required with regular attempts made to discontinue treatment. Vaginal oestrogen may be required long term. When stopping HRT it is important to tell women that gradually reducing HRT is effective at limiting recurrence only in the short term. In the long term, there is no difference in symptom control. <br /><br />Although menopausal symptoms can be managed mainly in primary care, there are some instances when a woman should be referred to secondary care. She should be referred to secondary care if treatment has been ineffective, if there are ongoing side effects or if there is unexplained bleeding.",
        "notes_hash": "58e05deffbd4e95e6bd21ab6aabfdf67",
        "knowledge_graph_node_id_link": 1160,
        "concept": "Selective serotonin reuptake inhibitors and venlafaxine are non-hormonal methods that may help vasomotor symptoms of menopause",
        "concept_percentile": "99",
        "concept_colour": "rgb(5,255,0)",
        "number_attempts": "5870",
        "up_votes": "59",
        "down_votes": "21",
        "column_array": [
            0,
            "1438",
            "3232",
            "577",
            "425",
            "198",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjBxRLhyd2I\" data-description=\"Menopause\" data-upvotes=\"5\" data-downvotes=\"4\" data-media=\"470\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hjBxRLhyd2I/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hjBxRLhyd2I\" data-description=\"Menopause\" data-upvotes=\"5\" data-downvotes=\"4\" data-media=\"470\">Menopause</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_825\" data-mediaid=\"825\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_825\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_825\" data-mediaid=\"825\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_825\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/rxZBn88iUlM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rxZBn88iUlM\" data-description=\"Premature ovarian failure\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"384\">Premature ovarian failure</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_658\" data-mediaid=\"658\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_658\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_658\" data-mediaid=\"658\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_658\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "3065": {
                "concept_text": "Selective serotonin reuptake inhibitors and venlafaxine are non-hormonal methods that may help vasomotor symptoms of menopause",
                "concept_percentile": "99"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1479_B_189",
        "new_question_id": "2020",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1246",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "There is currently no screening programme for ovarian cancer",
            "Screening is offered to all women after 50 with 3 yearly transvaginal ultrasounds",
            "Screening is offered to all women after 50 with 3 yearly measuring of Ca125 levels",
            "Screening is only offered to women who have a family history of ovarian cancer",
            "Screening is only offered to women who have the BRCA1 or BRCA2 gene",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 33-year-old woman reports that both her mother and grandmother died of ovarian cancer in their 40s. She is worried that she too may develop the condition and would like to know more about screening for ovarian cancer in the UK <br /><br />Which one of the following is true?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "At the moment, there is no screening test that reliably detects ovarian cancer at an early stage.<br /><br />Ovarian cancer should be suspected and further tests should be carried out in any woman (particularly those over 50 years of age), who persistently have any of the following symptoms:<br /><br /><ul><li>Abdominal distension/bloating</li><li>Feeling full (early satiety) or loss of appetite</li><li>Pelvic or abdominal pain.</li><li>Increased urinary urgency or frequency</li></ul>",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 33-year-old woman reports that both her mother and grandmother died of ovarian cancer in their 40s. She is worried that she too may develop the condition and would like to know more about screening for ovarian cancer in the UK <br /><br />Which one of the following is true?",
        "correct_answer": "1",
        "question_notes": "At the moment, there is no screening test that reliably detects ovarian cancer at an early stage.<br /><br />Ovarian cancer should be suspected and further tests should be carried out in any woman (particularly those over 50 years of age), who persistently have any of the following symptoms:<br /><br /><ul><li>Abdominal distension/bloating</li><li>Feeling full (early satiety) or loss of appetite</li><li>Pelvic or abdominal pain.</li><li>Increased urinary urgency or frequency</li></ul>",
        "answer_order": "1",
        "answer": "1",
        "title": "Ovarian cancer",
        "body": "Ovarian cancer is the sixth most common malignancy in females in the UK. The peak age of incidence is 60 years and it generally carries a poor prognosis due to late diagnosis.<br /><br />Pathophysiology<br /><ul><li><span class=\"concept\" data-cid=\"8492\">around 90% of ovarian cancers are epithelial in origin, with 70\u201380% of cases being due to serous carcinomas</span></li><li>interestingly, it is now increasingly recognised that the distal end of the fallopian tube is often the site of origin of many 'ovarian' cancers</li></ul><br />Risk factors<br /><ul><li>family history: mutations of the <span class=\"concept\" data-cid=\"7782\">BRCA1</span> or the <span class=\"concept\" data-cid=\"7783\">BRCA2 gene</span></li><li><span class=\"concept\" data-cid=\"250\">many ovulations</span>: <ul><li><span class=\"concept\" data-cid=\"7784\">early menarche</span></li><li><span class=\"concept\" data-cid=\"7785\">late menopause</span></li><li><span class=\"concept\" data-cid=\"7786\">nulliparity</span></li></ul></li><li>protective factors: multiple pregnancies, breastfeeding, use of the combined oral contraceptive pill</li><li>tubal ligation or salpingectomy are also associated with reduced risk</li></ul><br />Clinical features are notoriously <span class=\"concept\" data-cid=\"251\">vague</span><br /><ul><li>abdominal distension and bloating</li><li>abdominal and pelvic pain</li><li>urinary symptoms e.g. urgency</li><li>early satiety</li><li>diarrhoea</li><li>unexplained weight loss</li><li>fatigue</li><li>ascites</li></ul><br />Investigations<br /><ul><li>CA125<ul><li>NICE recommends a CA125 test is done initially. Endometriosis, menstruation, benign ovarian cysts and other conditions may also raise the CA125 level</li><li>if the CA125 is raised (35 IU/mL or greater) then an urgent ultrasound scan of the abdomen and pelvis should be ordered</li><li><span class=\"concept\" data-cid=\"9753\">a CA125 should not be used for screening for ovarian cancer in asymptomatic women</span></li></ul></li><li>ultrasound</li><li>if ascites or a pelvic mass is detected on examination, urgent referral via a suspected cancer pathway should be considered</li><li>in secondary care, the <span class=\"concept\" data-cid=\"3971\">Risk of Malignancy Index (RMI)</span> may be used to stratify risk and guide referral to a specialist centre</li></ul><br />Diagnosis<br /><ul><li><span class=\"concept\" data-cid=\"12427\">diagnostic laparoscopy</span><ul><li>allows direct visualisation of the pelvis, peritoneal surfaces and diaphragm</li><li>peritoneal washings and targeted biopsies can be taken to obtain histology</li><li>enables assessment of resectability</li><li>staging information gained at laparoscopy helps tailor subsequent surgical and systemic therapy decisions</li></ul></li></ul><br />Management<br /><ul><li>all patients should be managed through a specialist gynaecological oncology multidisciplinary team (MDT)</li><li>definitive treatment strategies<ul><li><b>primary cytoreductive surgery</b> (total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy \u00b1 bowel/peritoneal resection) followed by adjuvant platinum-based chemotherapy is preferred when optimal (<1 cm residual disease) debulking appears feasible</li><li>where optimal primary debulking is unlikely, <b>neoadjuvant chemotherapy</b> (usually 3 cycles of carboplatin and paclitaxel) is given first, followed by interval debulking surgery and further chemotherapy</li><li>intraperitoneal chemotherapy is rarely used in the UK but may be considered in selected centres</li></ul></li><li>systemic therapy enhancements<ul><li>bevacizumab (anti-VEGF monoclonal antibody) may be added to first-line chemotherapy in advanced disease</li><li>PARP inhibitors (e.g. olaparib, niraparib) are offered as maintenance therapy, particularly in <b>BRCA-mutated</b> or homologous-recombination-deficient tumours</li></ul></li><li>supportive and palliative care<ul><li>management of malignant ascites (paracentesis, indwelling peritoneal drains) and bowel obstruction</li></ul></li></ul><br />Prognosis<br /><ul><li>80% of women have advanced disease at presentation</li><li>the all-stage 5-year survival is <b>around 46%</b>, but varies significantly with stage at diagnosis</li></ul>",
        "notes_hash": "a3a4664d3e8bc349410d3735da094908",
        "knowledge_graph_node_id_link": 1021,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5373",
        "up_votes": "33",
        "down_votes": "10",
        "column_array": [
            0,
            "3051",
            "196",
            "382",
            "829",
            "915",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Royal College of Obstetricians and Gynaecologists</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_132\" data-linkid=\"132\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_132\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_132\" data-linkid=\"132\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_132\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_62.pdf\">2011 Management of Suspected Ovarian Masses in Premenopausal Women</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_695\" data-linkid=\"695\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_695\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"link_dislike_695\" data-linkid=\"695\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_695\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.nice.org.uk/guidance/cg122/chapter/1-Guidance\">2011 Ovarian cancer guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lCOnSW2hkV4\" data-description=\"Ovarian tumors\" data-upvotes=\"5\" data-downvotes=\"0\" data-media=\"341\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/lCOnSW2hkV4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lCOnSW2hkV4\" data-description=\"Ovarian tumors\" data-upvotes=\"5\" data-downvotes=\"0\" data-media=\"341\">Ovarian tumors</a></td></tr><tr><td><span ><small>12DaysinMarch - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_580\" data-mediaid=\"580\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_580\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_580\" data-mediaid=\"580\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_580\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sPWc2rDfhHU\" data-description=\"Sex cord-stromal ovarian cancer\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"333\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/sPWc2rDfhHU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sPWc2rDfhHU\" data-description=\"Sex cord-stromal ovarian cancer\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"333\">Sex cord-stromal ovarian cancer</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_563\" data-mediaid=\"563\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_563\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_563\" data-mediaid=\"563\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_563\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/aDXkyhEnWBE\" data-description=\"Ovarian cancer\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1461\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/aDXkyhEnWBE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/aDXkyhEnWBE\" data-description=\"Ovarian cancer\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1461\">Ovarian cancer</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2574\" data-mediaid=\"2574\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2574\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2574\" data-mediaid=\"2574\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2574\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/b/be/Epithelial_ovarian_cancer.webm\" data-description=\"Epithelial ovarian cancer\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"332\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/b/be/Epithelial_ovarian_cancer.webm\" data-description=\"Epithelial ovarian cancer\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"332\">Epithelial ovarian cancer</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_562\" data-mediaid=\"562\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_562\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_562\" data-mediaid=\"562\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_562\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/e/e9/Germ_cell_ovarian_cancer.webm\" data-description=\"Germ cell ovarian cancer\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"991\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/e/e9/Germ_cell_ovarian_cancer.webm\" data-description=\"Germ cell ovarian cancer\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"991\">Germ cell ovarian cancer</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1731\" data-mediaid=\"1731\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1731\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_1731\" data-mediaid=\"1731\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1731\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "250": {
                "concept_text": "Ovarian cancer: risk factors relate to increased number of ovulations",
                "concept_percentile": "86"
            },
            "7782": {
                "concept_text": "Ovarian cancer - risk factors include: mutations of the BRCA1 gene",
                "concept_percentile": "31"
            },
            "7783": {
                "concept_text": "Ovarian cancer - risk factors include: mutations of the BRCA2 gene",
                "concept_percentile": "63"
            },
            "7784": {
                "concept_text": "Ovarian cancer - risk factors include: early menarche",
                "concept_percentile": "52"
            },
            "7785": {
                "concept_text": "Ovarian cancer - risk factors include: late menopause",
                "concept_percentile": "21"
            },
            "7786": {
                "concept_text": "Ovarian cancer - risk factors include: nulliparity",
                "concept_percentile": "19"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "16718_B_314",
        "new_question_id": "32272",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "4229",
        "notes_id_link": "1_2698",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Incarcerated femoral hernia",
            "Incarcerated inguinal hernia",
            "Perforated peptic ulcer",
            "Strangulated femoral hernia",
            "Strangulated inguinal hernia",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 67-year-old male presents to the emergency department complaining of new-onset pain in his left groin. On examination, a large, warm, non-reducible mass located inferolateral to the pubic tubercle can be observed. It is accompanied by erythema of the overlying skin. When asked, he admits to vomiting twice and passing stools with blood mixed in them once. He looks in pain and sweaty. He has a past medical history of peptic ulcer disease, managed with omeprazole. <br /><br />Which one of the following is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is a strangulated femoral hernia. This patient is presenting with a non-reducible mass located inferolateral to the pubic tubercle with erythema of the overlying skin. The position is characteristic of a femoral hernia. The features accompanying it, such as vomiting, the passage of bloody stools, and the patient having a toxic appearance, are in keeping with a diagnosis of strangulated femoral hernia. Strangulation happens when the blood supply to the herniated tissue is compromised, leading to ischemia or necrosis. <br /><br />An incarcerated femoral hernia would present as a non-reducible mass inferolateral to the pubic tubercle. These hernias are at high risk of strangulation but they have not lost their blood supply yet. The sick appearance of the patient, accompanied by symptoms of necrosis such as vomiting and bloody stool indicates that strangulation has occurred. <br /><br />Incarcerated inguinal hernias are non-reducible masses superior and medial to the pubic tubercle. They do not cause symptoms of strangulation. <br /><br />A perforated peptic ulcer would present with epigastric pain, syncope, and possibly haematemesis. This patient's complaint is focused on the groin area rather than the epigastric area. <br /><br />A strangulated inguinal hernia would present with similar symptoms such as systemic upset, pain, erythema, vomiting, and bloody stools. But the mass would be superior and medial to the pubic tubercle rather than inferolateral.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 67-year-old male presents to the emergency department complaining of new-onset pain in his left groin. On examination, a large, warm, non-reducible mass located inferolateral to the pubic tubercle can be observed. It is accompanied by erythema of the overlying skin. When asked, he admits to vomiting twice and passing stools with blood mixed in them once. He looks in pain and sweaty. He has a past medical history of peptic ulcer disease, managed with omeprazole. <br /><br />Which one of the following is the most likely diagnosis?",
        "correct_answer": "4",
        "question_notes": "The correct answer is a strangulated femoral hernia. This patient is presenting with a non-reducible mass located inferolateral to the pubic tubercle with erythema of the overlying skin. The position is characteristic of a femoral hernia. The features accompanying it, such as vomiting, the passage of bloody stools, and the patient having a toxic appearance, are in keeping with a diagnosis of strangulated femoral hernia. Strangulation happens when the blood supply to the herniated tissue is compromised, leading to ischemia or necrosis. <br /><br />An incarcerated femoral hernia would present as a non-reducible mass inferolateral to the pubic tubercle. These hernias are at high risk of strangulation but they have not lost their blood supply yet. The sick appearance of the patient, accompanied by symptoms of necrosis such as vomiting and bloody stool indicates that strangulation has occurred. <br /><br />Incarcerated inguinal hernias are non-reducible masses superior and medial to the pubic tubercle. They do not cause symptoms of strangulation. <br /><br />A perforated peptic ulcer would present with epigastric pain, syncope, and possibly haematemesis. This patient's complaint is focused on the groin area rather than the epigastric area. <br /><br />A strangulated inguinal hernia would present with similar symptoms such as systemic upset, pain, erythema, vomiting, and bloody stools. But the mass would be superior and medial to the pubic tubercle rather than inferolateral.",
        "answer_order": "4",
        "answer": "4",
        "title": "Femoral hernia",
        "body": "Femoral hernias occur when a section of the bowel or any other part of the abdominal viscera pass into the femoral canal. The canal is usually a densely packed area of the anterior thigh, however, it is a potential space that can become occupied by herniated contents via the <b>femoral ring</b>.<br /><br />Features:<br /><ul><li>A lump within the groin, that is usually mildly painful;</li><li>It is important to distinguish femoral hernias, which are <span class=\"concept\" data-cid=\"11977\"><b>inferolateral</b></span> to the pubic tubercle, from inguinal hernias which are <b>supermedial</b> to the pubic tubercle;</li><li>Typically non-reducible, although can be reducible in a minority of cases;</li><li>Given the small size of the femoral ring, a cough impulse is often absent.</li></ul><br />Epidemiology<br /><ul><li>Much less common than inguinal hernias (only 5% of abdominal hernias are femoral)</li><li><span class=\"concept\" data-cid=\"5312\">More common in women (M:F 1:3)</span><ul><li>The effects of increased abdominal pressure in pregnancy measn that femoral hernias are more common in multiparous women compared to nulliparous women.</li></ul></li></ul><br />Diagnosis is usually clinical, although ultrasound is an option. As with any lump, wherever it may be located, there are important differentials to exclude for femoral hernias:<br /><ul><li>Lymphadenopathy</li><li>Abscess</li><li>Femoral artery aneurysm</li><li>Hydrocoele or varicocele in males</li><li>Lipoma</li><li>Inguinal hernia</li></ul><br />Complications<br /><ul><li>Incarceration, where the herniated tissue cannot be reduced</li><li><span class=\"concept\" data-cid=\"4229\">Strangulation</span><ul><li>Can follow on from incarceration, and is a <b>surgical emergency</b> that requires urgent management (see below)</li><li>These hernias will be <span class=\"concept\" data-cid=\"11978\">tender and likely non-reducible</span>, and may also present with a systemically unwell patient</li><li>The risk of strangulation is much higher with femoral hernias than inguinal hernias and increases as the time from diagnosis rises; </li></ul></li><li>Bowel obstruction, again a <b>surgical emergency</b></li><li>Bowel ischaemia and resection due to the above, which may lead to significant morbidity and mortality for the patient.</li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"11643\">Surgical repair is a <b>necessity</b>, given the risk of strangulation</span>, and can be carried out either laparoscopically or via a laparotomy</li><li>Hernia support belts/trusses should not be used for femoral hernias, again due to the risk of strangulation;</li><li>In an emergency situation, a laparotomy may be the only option</li></ul>",
        "notes_hash": "bf3bf32ac3c17b19527b67cb0cec19f1",
        "knowledge_graph_node_id_link": 1249,
        "concept": "Strangulation is an important complication of femoral hernias",
        "concept_percentile": "85",
        "concept_colour": "rgb(76,255,0)",
        "number_attempts": "5967",
        "up_votes": "51",
        "down_votes": "42",
        "column_array": [
            0,
            "1303",
            "719",
            "60",
            "2778",
            "1107",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 7,
        "concepts_for_notes": {
            "4229": {
                "concept_text": "Strangulation is an important complication of femoral hernias",
                "concept_percentile": "85"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "2084_B_178",
        "new_question_id": "17312",
        "question_type": "0",
        "category": "12",
        "concept_id_link": "5135",
        "notes_id_link": "9_608",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "pH = 7.19, pO<sub>2</sub> = 10.1 kPa, pCO<sub>2</sub> = 2.3 kPa, HCO<sub>3</sub><sup>-</sup> = 12 mmol/l",
            "pH = 7.39, pO<sub>2</sub> = 10.9 kPa, pCO<sub>2</sub> = 4.9 kPa, HCO<sub>3</sub><sup>-</sup> = 25 mmol/l",
            "pH = 7.48, pO<sub>2</sub> = 7.9 kPa, pCO<sub>2</sub> = 2.3 kPa, HCO<sub>3</sub><sup>-</sup> = 24 mmol/l",
            "pH = 7.25, pO<sub>2</sub> = 10.6 kPa, pCO<sub>2</sub> = 6.2 kPa, HCO<sub>3</sub><sup>-</sup> = 18 mmol/l",
            "pH = 7.37, pO<sub>2</sub> = 9.1 kPa, pCO<sub>2</sub> = 6.1 kPa, HCO<sub>3</sub><sup>-</sup> = 30 mmol/l",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 53-year-old man is seen in the respiratory clinic for chronic obstructive pulmonary disease follow up. He is known to have chronic CO<sub>2</sub> retention and his oxygen saturation targets are 88-92%. On examination his chest sounds quiet throughout but with equal air expansion, the appearance of a hyper-expanded chest and his oxygen saturations are 91% on air. An arterial blood gas is performed in the clinic.<br /><br />Which of the following blood gas results would you most expect to see in this man?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "The only option which would fit with a chronic picture of CO<sub>2</sub> retention would be number 5 as this has the raised bicarbonate which is a result of chronic renal compensation of the acidosis. The pH is also within the normal range as this acidosis is fully compensated and the pO<sub>2</sub> is low in keeping with the low saturations of 91%.<br /><br />Option 2 reflects a normal blood gas result. The normal values of arterial blood gases are shown in the table below:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Parameter</th><th>Normal Range</th></tr></thead><tbody><tr><td>pH</td><td>7.35 - 7.45</td></tr><tr><td>pO<sub>2</sub></td><td>10.0 - 14.0 kPa</td></tr><tr><td>pCO<sub>2</sub></td><td>4.5 - 6.0 kPa</td></tr><tr><td>HCO<sub>3</sub><sup>-</sup></td><td>22 - 26 mmol/l</td></tr></tbody></table></div>In option 1 the pH is low indicating an acidosis with a very low bicarbonate indicating a metabolic cause. In this case the pCO<sub>2</sub> is also low indicated an attempt at respiratory compensation.<br /><br />The pH in option 3 is high indicating an alkalosis with a low CO<sub>2</sub> and normal bicarbonate indicating a respiratory cause.<br /><br />Lastly option 4 demonstrates a mixed acidosis with a low pH and both a raised pCO<sub>2</sub> and a low bicarbonate.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 53-year-old man is seen in the respiratory clinic for chronic obstructive pulmonary disease follow up. He is known to have chronic CO<sub>2</sub> retention and his oxygen saturation targets are 88-92%. On examination his chest sounds quiet throughout but with equal air expansion, the appearance of a hyper-expanded chest and his oxygen saturations are 91% on air. An arterial blood gas is performed in the clinic.<br /><br />Which of the following blood gas results would you most expect to see in this man?",
        "correct_answer": "5",
        "question_notes": "The only option which would fit with a chronic picture of CO<sub>2</sub> retention would be number 5 as this has the raised bicarbonate which is a result of chronic renal compensation of the acidosis. The pH is also within the normal range as this acidosis is fully compensated and the pO<sub>2</sub> is low in keeping with the low saturations of 91%.<br /><br />Option 2 reflects a normal blood gas result. The normal values of arterial blood gases are shown in the table below:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Parameter</th><th>Normal Range</th></tr></thead><tbody><tr><td>pH</td><td>7.35 - 7.45</td></tr><tr><td>pO<sub>2</sub></td><td>10.0 - 14.0 kPa</td></tr><tr><td>pCO<sub>2</sub></td><td>4.5 - 6.0 kPa</td></tr><tr><td>HCO<sub>3</sub><sup>-</sup></td><td>22 - 26 mmol/l</td></tr></tbody></table></div>In option 1 the pH is low indicating an acidosis with a very low bicarbonate indicating a metabolic cause. In this case the pCO<sub>2</sub> is also low indicated an attempt at respiratory compensation.<br /><br />The pH in option 3 is high indicating an alkalosis with a low CO<sub>2</sub> and normal bicarbonate indicating a respiratory cause.<br /><br />Lastly option 4 demonstrates a mixed acidosis with a low pH and both a raised pCO<sub>2</sub> and a low bicarbonate.",
        "answer_order": "5",
        "answer": "5",
        "title": "Arterial blood gas interpretation",
        "body": "The Resuscitation Council (UK) advocate a 5 step approach to arterial blood gas interpretation.<br /><br />1. How is the patient?<br /><br />2. Is the patient hypoxaemic?<br /><ul><li>the Pa0<sub>2</sub> on air should be >10 kPa</li></ul><br />3. Is the patient acidaemic (pH <7.35) or alkalaemic (pH >7.45)<br /><br />4. Respiratory component: What has happened to the PaCO<sub>2</sub>?<br /><ul><li>PaCO<sub>2</sub> > 6.0 kPa suggests a respiratory acidosis (or respiratory compensation for a metabolic alkalosis)</li><li>PaCO<sub>2</sub> < 4.7 kPa suggests a respiratory alkalosis (or respiratory compensation for a metabolic acidosis)</li></ul><br />5. Metabolic component: What is the bicarbonate level/base excess?<br /><ul><li>bicarbonate < 22 mmol/l (or a base excess < - 2mmol/l) suggests a metabolic acidosis (or renal compensation for a respiratory alkalosis)</li><li>bicarbonate > 26 mmol/l (or a base excess > + 2mmol/l) suggests a metabolic alkalosis (or renal compensation for a respiratory acidosis)</li></ul><br /><div class='alert alert-warning'><h5 class='notes-heading'>ROME</h5><br /><b>R</b>espiratory = <b>O</b>pposite<br /><ul><li> low pH + high PaCO<sub>2</sub> i.e. acidosis, or </li><li> high pH + low PaCO<sub>2</sub> i.e. alkalosis</li></ul><br /><b>M</b>etabolic = <b>E</b>qual<br /><ul><li> low pH + low bicarbonate i.e. acidosis, or</li><li> high pH + high bicarbonate i.e. akalosis</li></ul></div>",
        "notes_hash": "511eda760ce71f03a420f65e4f7f3294",
        "knowledge_graph_node_id_link": 0,
        "concept": "ABG triad for chronic CO2 retention: <br /><ul><li>Normal pH</li><li>High pCO2</li><li>High HCO3</li></ul>",
        "concept_percentile": "95",
        "concept_colour": "rgb(25,255,0)",
        "number_attempts": "6453",
        "up_votes": "43",
        "down_votes": "15",
        "column_array": [
            0,
            "145",
            "309",
            "221",
            "1872",
            "3906",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sQnEFVNrY74\" data-description=\"Anion Gap EXPLAINED\" data-upvotes=\"14\" data-downvotes=\"0\" data-media=\"674\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/sQnEFVNrY74/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sQnEFVNrY74\" data-description=\"Anion Gap EXPLAINED\" data-upvotes=\"14\" data-downvotes=\"0\" data-media=\"674\">Anion Gap EXPLAINED</a></td></tr><tr><td><span ><small>HippocraTV - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1168\" data-mediaid=\"1168\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1168\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"media_dislike_1168\" data-mediaid=\"1168\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1168\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dg1IfEr_vEE\" data-description=\"Blood Gas Interpretation Made Easy\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1469\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/dg1IfEr_vEE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/dg1IfEr_vEE\" data-description=\"Blood Gas Interpretation Made Easy\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1469\">Blood Gas Interpretation Made Easy</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2589\" data-mediaid=\"2589\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2589\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_2589\" data-mediaid=\"2589\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2589\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/stgY1QgpGxU\" data-description=\"Acid-base disturbances\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1266\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/stgY1QgpGxU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/stgY1QgpGxU\" data-description=\"Acid-base disturbances\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1266\">Acid-base disturbances</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2240\" data-mediaid=\"2240\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2240\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2240\" data-mediaid=\"2240\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2240\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gPHLeHUZE3k\" data-description=\"Understanding Arterial Blood Gases\" data-upvotes=\"10\" data-downvotes=\"1\" data-media=\"1253\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/gPHLeHUZE3k/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/gPHLeHUZE3k\" data-description=\"Understanding Arterial Blood Gases\" data-upvotes=\"10\" data-downvotes=\"1\" data-media=\"1253\">Understanding Arterial Blood Gases</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2213\" data-mediaid=\"2213\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2213\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"media_dislike_2213\" data-mediaid=\"2213\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2213\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/0gbjvsxuT8o\" data-description=\"ABG Interpretation Made Easy\" data-upvotes=\"14\" data-downvotes=\"2\" data-media=\"1229\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/0gbjvsxuT8o/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/0gbjvsxuT8o\" data-description=\"ABG Interpretation Made Easy\" data-upvotes=\"14\" data-downvotes=\"2\" data-media=\"1229\">ABG Interpretation Made Easy</a></td></tr><tr><td><span ><small>Respiratory Therapy Zone - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2158\" data-mediaid=\"2158\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2158\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"media_dislike_2158\" data-mediaid=\"2158\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2158\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    }
]